Absci (ABSI) Net Margin (QoQ) (2020 - 2026)
Absci (ABSI) Net Margin (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -921,898.00 |
| Dec 31, 2025 | 304,618.00 |
| Sep 30, 2025 | -243,921.00 |
| Jun 30, 2025 | -292,037.00 |
| Mar 31, 2025 | 212,374.00 |
| Dec 31, 2024 | -274,765.00 |
| Sep 30, 2024 | 33,812.00 |
| Jun 30, 2024 | 49,829.00 |
| Mar 31, 2024 | 451,887.00 |
| Dec 31, 2023 | -400,979.00 |
| Sep 30, 2023 | -171,852.00 |
| Jun 30, 2023 | 60,277.00 |
| Mar 31, 2023 | 390,323.00 |
| Dec 31, 2022 | 172,456.00 |
| Sep 30, 2022 | -460,594.00 |
| Jun 30, 2022 | 521,827.00 |
| Mar 31, 2022 | -925,160.00 |
| Dec 31, 2021 | 1.72 Mn |
| Sep 30, 2021 | -1.02 Mn |
| Jun 30, 2021 | -467,805.00 |